199 related articles for article (PubMed ID: 34785398)
21. Polyomavirus Wakes Up and Chooses Neurovirulence.
Butic AB; Spencer SA; Shaheen SK; Lukacher AE
Viruses; 2023 Oct; 15(10):. PubMed ID: 37896889
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of JC polyomavirus infectivity by the retrograde transport inhibitor Retro-2.1.
Treasure T; Nelson CDS
Microbiol Immunol; 2020 Dec; 64(12):783-791. PubMed ID: 32965709
[TBL] [Abstract][Full Text] [Related]
23. JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection.
Maginnis MS; Nelson CD; Atwood WJ
J Neurovirol; 2015 Dec; 21(6):601-13. PubMed ID: 25078361
[TBL] [Abstract][Full Text] [Related]
24. Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation.
Mani J; Jin N; Schmitt M
Cytotherapy; 2014 Oct; 16(10):1325-35. PubMed ID: 24934303
[TBL] [Abstract][Full Text] [Related]
25. JC Polyomavirus Entry by Clathrin-Mediated Endocytosis Is Driven by β-Arrestin.
Mayberry CL; Soucy AN; Lajoie CR; DuShane JK; Maginnis MS
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700597
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy.
Muftuoglu M; Olson A; Marin D; Ahmed S; Mulanovich V; Tummala S; Chi TL; Ferrajoli A; Kaur I; Li L; Champlin R; Shpall EJ; Rezvani K
N Engl J Med; 2018 Oct; 379(15):1443-1451. PubMed ID: 30304652
[TBL] [Abstract][Full Text] [Related]
27. High-throughput drug screen identifies calcium and calmodulin inhibitors that reduce JCPyV infection.
Bond ACS; Crocker MA; Wilczek MP; DuShane JK; Sandberg AL; Bennett LJ; Leclerc NR; Maginnis MS
Antiviral Res; 2024 Feb; 222():105817. PubMed ID: 38246207
[TBL] [Abstract][Full Text] [Related]
28. CD8 T Cells and STAT1 Signaling Are Essential Codeterminants in Protection from Polyomavirus Encephalopathy.
Mockus TE; Netherby-Winslow CS; Atkins HM; Lauver MD; Jin G; Ren HM; Lukacher AE
J Virol; 2020 Mar; 94(8):. PubMed ID: 31996425
[TBL] [Abstract][Full Text] [Related]
29. Prevention and therapy of JC polyomavirus-mediated progressive multifocal leukoencephalopathy - a realistic possibility?
Jelcic I; Combaluzier B; Jelcic I; Sospedra M; Grimm J; Martin R
Swiss Med Wkly; 2017; 147():w14520. PubMed ID: 29120025
[TBL] [Abstract][Full Text] [Related]
30. The human JC polyomavirus (JCPyV): virological background and clinical implications.
Hirsch HH; Kardas P; Kranz D; Leboeuf C
APMIS; 2013 Aug; 121(8):685-727. PubMed ID: 23781977
[TBL] [Abstract][Full Text] [Related]
31. Serum IgG antibodies from healthy subjects up to 100 years old react to JC polyomavirus.
Bononi I; Mazzoni E; Pietrobon S; Manfrini M; Torreggiani E; Rossini M; Lotito F; Guerra G; Rizzo P; Martini F; Tognon M
J Cell Physiol; 2018 Aug; 233(8):5513-5522. PubMed ID: 29323725
[TBL] [Abstract][Full Text] [Related]
32. Fifty Years of JC Polyomavirus: A Brief Overview and Remaining Questions.
Atkinson AL; Atwood WJ
Viruses; 2020 Sep; 12(9):. PubMed ID: 32882975
[TBL] [Abstract][Full Text] [Related]
33. The Oxindole GW-5074 Inhibits JC Polyomavirus Infection and Spread by Antagonizing the MAPK-ERK Signaling Pathway.
Kaiserman J; O'Hara BA; Garabian K; Lukacher A; Haley SA; Atwood WJ
mBio; 2023 Apr; 14(2):e0358322. PubMed ID: 36786589
[TBL] [Abstract][Full Text] [Related]
34. Undetectable JC virus CSF PCR in patients with JC virus-induced progressive multifocal leukoencephalopathy.
Chiu CY; Amenta E; Chavez V; Fukuta Y; Hasbun R
J Neurovirol; 2023 Feb; 29(1):94-99. PubMed ID: 36723823
[TBL] [Abstract][Full Text] [Related]
35. Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes.
Steinhardt MJ; Wiercinska E; Pham M; Grigoleit GU; Mazzoni A; Da-Via M; Zhou X; Meckel K; Nickel K; Duell J; Krummenast FC; Kraus S; Hopkinson C; Weissbrich B; Müllges W; Stoll G; Kortüm KM; Einsele H; Bonig H; Rasche L
J Transl Med; 2020 Apr; 18(1):177. PubMed ID: 32316991
[TBL] [Abstract][Full Text] [Related]
36. Studies of human polyomaviruses, with HPyV7, BKPyV, and JCPyV present in urine of allogeneic hematopoietic stem cell transplanted patients with or without hemorrhagic cystitis.
Franzén J; Ramqvist T; Bogdanovic G; Grün N; Mattson J; Dalianis T
Transpl Infect Dis; 2016 Apr; 18(2):240-6. PubMed ID: 26809742
[TBL] [Abstract][Full Text] [Related]
37. Single-Molecule Sequencing Revealing the Presence of Distinct JC Polyomavirus Populations in Patients With Progressive Multifocal Leukoencephalopathy.
Seppälä H; Virtanen E; Saarela M; Laine P; Paulín L; Mannonen L; Auvinen P; Auvinen E
J Infect Dis; 2017 Mar; 215(6):889-895. PubMed ID: 28453853
[TBL] [Abstract][Full Text] [Related]
38. Long-Term Follow-Up after Adoptive Transfer of BK-Virus-Specific T Cells in Hematopoietic Stem Cell Transplant Recipients.
Koldehoff M; Eiz-Vesper B; Maecker-Kolhoff B; Steckel NK; Dittmer U; Horn PA; Lindemann M
Vaccines (Basel); 2023 Apr; 11(4):. PubMed ID: 37112757
[TBL] [Abstract][Full Text] [Related]
39. Polyomaviruses BK, JC, KI, WU, MC, and TS in children with allogeneic hematopoietic stem cell transplantation.
Rahiala J; Koskenvuo M; Sadeghi M; Waris M; Vuorinen T; Lappalainen M; Saarinen-Pihkala U; Allander T; Söderlund-Venermo M; Hedman K; Ruuskanen O; Vettenranta K
Pediatr Transplant; 2016 May; 20(3):424-31. PubMed ID: 27038301
[TBL] [Abstract][Full Text] [Related]
40. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
